Peter Grünefeld

Title: Innovations by Peter Grünefeld in Extracellular Nucleic Acid Isolation

Introduction

Peter Grünefeld is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of biotechnology, particularly in the isolation of extracellular nucleic acids. With a total of 2 patents, his work has advanced methodologies that are crucial for various applications in research and diagnostics.

Latest Patents

One of Peter Grünefeld's latest patents is a rapid method for isolating extracellular nucleic acids. This invention pertains to a method that allows for the efficient extraction of extracellular nucleic acids from a sample. The process involves binding these nucleic acids to a solid phase with anion exchange groups. The method includes several steps: binding the nucleic acids in a binding mixture with a specific pH, separating the solid phase with the bound nucleic acids, and optionally washing and eluting the nucleic acids. This innovative approach enables the processing of large sample volumes and ensures a high yield of isolated nucleic acids, making it particularly suitable for automatable processes.

Career Highlights

Peter Grünefeld is associated with Qiagen GmbH, a leading company in the field of molecular biology. His work at Qiagen has allowed him to focus on developing methods that enhance the efficiency of nucleic acid isolation, contributing to advancements in the biotechnology sector.

Collaborations

Throughout his career, Peter has collaborated with notable colleagues such as Martin Horlitz and Annette Nocon. These collaborations have fostered an environment of innovation and have led to the development of impactful technologies in the field.

Conclusion

Peter Grünefeld's contributions to the field of biotechnology, particularly in the isolation of extracellular nucleic acids, highlight his role as an influential inventor. His innovative methods and collaborations continue to shape advancements in molecular biology.